FDA's Eased Oversight Is Good Omen For Health IT
New guidances from the U.S. Food and Drug Administration ease regulatory hurdles for low-risk medical devices in important ways and bode well for looming decisions on how strictly to police next-generation...To view the full article, register now.
Already a subscriber? Click here to view full article